SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Cancer Research Breakthrough In Texas
September 5, 2006
 · 
1 min read
Lone Star Bio
Keep Kidney Stones Away With Orange Juice, Not Lemonade
September 5, 2006
 · 
1 min read
Lone Star Bio
Orange Juice Is Better Than Lemonade At Keeping Kidney Stones Away
August 31, 2006
 · 
1 min read
Lone Star Bio
Proton Therapy Used More To Treat Cancer
August 22, 2006
 · 
1 min read
Lone Star Bio
Genetic Clues To Cardiomyopathy’s Origins Revealed In Mice
August 18, 2006
 · 
1 min read
BioCapital
Digital DNA Detector Spots Single Molecules
August 15, 2006
 · 
1 min read
Drug Development
Fatty Spheres Loaded With Sirna Shrink Ovarian Cancer Tumors In Preclinical Trial
August 15, 2006
 · 
1 min read
Lone Star Bio
Herceptin “Linked To Heart Risk”
August 15, 2006
 · 
1 min read
Lone Star Bio
Researchers Find “Secret Weapon” Used by SARS Virus
August 8, 2006
 · 
1 min read
Lone Star Bio
Researchers Identify Gene As Protector of DNA, Enemy of Tumors
August 4, 2006
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook
January 16, 2026
 · 
11 min read
Press Releases
Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology
January 15, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
January 15, 2026
 · 
5 min read
Press Releases
Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects
January 14, 2026
 · 
6 min read
Press Releases
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 13, 2026
 · 
1 min read
Press Releases
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
January 13, 2026
 · 
7 min read
Press Releases
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
January 13, 2026
 · 
9 min read
Press Releases
TYBR Health Appoints Jeff Tyber to Board of Directors
January 13, 2026
 · 
2 min read
Press Releases
Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity
January 13, 2026
 · 
6 min read
Press Releases
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
January 13, 2026
 · 
7 min read
Load More